back to list

ZIMENT ANNOUNCES JOHN TAPPER AS CHIEF METHODOLOGIST

NEW YORK, February 25, 2002 - John Tapper, Ph.D., a veteran of the pharmaceutical marketing research industry, has been named Ziment’s Chief Methodologist. Tapper brings to Ziment a wealth of healthcare marketing research and business strategy experience developed over the course of a career with several premier consultancies.

“Our clients face an increasingly complex array of problems. John’s ability to simplify these problems using sophisticated quantitative techniques will drive real benefits for them,” said Howard Ziment, CEO of Ziment. “We feel that John has the ideal mix of experience and talent to raise the bar even higher in terms of the creative insights we provide our clients using marketing research.”

Before joining Ziment, Tapper spent several years at a leading marketing research consultancy specializing in the pharmaceutical industry. Later, he joined a major international consulting firm as a marketing strategy principal, where he helped establish and lead the company’s quantitative marketing practice. Tapper’s experience spans a wide range of marketing problems, therapeutic categories, developmental phases, and geographies, having completed several multinational studies for blockbuster products.

“ Ziment’s deep knowledge of the healthcare and pharmaceutical industries provides the ideal environment in which to apply advanced multivariate techniques to complex problems in ways that drive powerful marketing strategies,” explained Tapper.

About Ziment, Inc.
Ziment is a global marketing research company based in New York City. It is the global healthcare brand for the Kantar Group, WPP’s Information and Consultancy Division. For over 25 years Ziment has offered full service marketing research primarily to the healthcare/pharmaceutical industries. More information about Ziment is available at www.ziment.com.

^ Top ^